JNJ - Johnson & Johnson Report

Johnson & Johnson (JNJ : NYQ)

Sector: Healthcare | Industry: Drug Manufacturers - General

$259.36

+5.57 (+2.19%)

MARKET CAP

$625.03B

FCF YIELD

N/A

CURRENT PRICE

$259.36

P/E RATIO

39.36x

Overview Financial Statements Metrics History DCF Valuation

INCOME STATEMENT (ANNUAL - 3-YEAR VIEW)

Financial Line Item	2025-12-31	2024-12-31	2023-12-31
1. REVENUE
Operating Revenue	$94.19B	$88.82B	$85.16B
Total Revenue	$94.19B	$88.82B	$85.16B
2. OPERATING EXPENSES
Reconciled Cost Of Revenue	$30.26B	$27.47B	$26.55B
Interest Expense	$971.00M	$755.00M	$772.00M
Tax Provision	$5.78B	$2.62B	$1.74B
Operating Expense	$38.34B	$40.10B	$36.60B
Research And Development	$14.66B	$17.23B	$15.09B
Selling General And Administration	$23.68B	$22.87B	$21.51B
Cost Of Revenue	$30.26B	$27.47B	$26.55B
Total Expenses	$68.60B	$67.57B	$63.15B
3. NET INCOME & EARNINGS DETAILS
Tax Effect Of Unusual Items	$1.04B	$-1.11B	$-92.23M
Tax Rate For Calcs	17.73%	15.71%	11.50%
Normalized EBITDA	$35.16B	$31.83B	$24.12B
Total Unusual Items	$5.89B	$-7.04B	$-802.00M
Total Unusual Items Excluding Goodwill	$5.89B	$-7.04B	$-802.00M
Net Income From Continuing Operation Net Minority Interest	$26.80B	$14.07B	$13.33B
Reconciled Depreciation	$7.50B	$7.34B	$7.49B
EBITDA	$41.05B	$24.78B	$23.32B
EBIT	$33.55B	$17.44B	$15.83B
Net Interest Income	$85.00M	$577.00M	$489.00M
Interest Income	$1.06B	$1.33B	$1.26B
Normalized Income	$21.96B	$20.00B	$14.04B
Net Income From Continuing And Discontinued Operation	$26.80B	$14.07B	$35.15B
Diluted Average Shares	2.43B	2.43B	2.56B
Basic Average Shares	2.41B	2.41B	2.41B
Diluted EPS	$11.03	$5.79	$13.72
Basic EPS	$11.13	$5.84	$14.60
Diluted NI Availto Com Stockholders	$26.80B	$14.07B	$35.15B
Net Income Including Noncontrolling Interests	$26.80B	$14.07B	$35.15B
Net Income Discontinuous Operations	$0.00	$0.00	$21.83B
Net Income Continuous Operations	$26.80B	$14.07B	$13.33B
Pretax Income	$32.58B	$16.69B	$15.06B
Other Income Expense	$6.89B	$-5.14B	$-7.44B
Other Non Operating Income Expenses	$1.00B	$1.90B	$-6.63B
Special Income Charges	$5.49B	$-6.75B	$-802.00M
Other Special Charges	$-6.00B	$5.50B	$7.30B
Impairment Of Capital Assets	$81.00M	$211.00M	$313.00M
Restructuring And Mergern Acquisition	$428.00M	$1.03B	$489.00M
Gain On Sale Of Security	$400.00M	$-300.00M	$-600.00M
Net Non Operating Interest Income Expense	$85.00M	$577.00M	$489.00M
Interest Expense Non Operating	$971.00M	$755.00M	$772.00M
Interest Income Non Operating	$1.06B	$1.33B	$1.26B
Operating Income	$25.60B	$21.25B	$22.01B
General And Administrative Expense	-	$22.87B	$21.51B
Other Gand A	-	$22.87B	$21.51B
Salaries And Wages	-	$-900.00M	$-1.40B
Gross Profit	$63.94B	$61.35B	$58.61B
Net Income Common Stockholders	$26.80B	$14.07B	$35.15B
Net Income	$26.80B	$14.07B	$35.15B

Financial Line Item	2025-12-31	2024-12-31	2023-12-31
1. ASSETS
1. Current Assets
Working Capital	$1.50B	$5.57B	$7.21B
Pensionand Other Post Retirement Benefit Plans Current	$4.53B	$4.13B	$3.99B
Assets Held For Sale Current	-	-	$0.00
Prepaid Assets	-	-	-
Inventory	$14.19B	$12.44B	$11.18B
Receivables	$21.33B	$18.93B	$19.39B
Other Receivables	$4.15B	$4.08B	$4.51B
Accounts Receivable	$17.18B	$14.84B	$14.87B
Allowance For Doubtful Accounts Receivable	$-183.00M	$-167.00M	$-166.00M
Gross Accounts Receivable	$17.36B	$15.01B	$15.04B
Cash Cash Equivalents And Short Term Investments	$20.10B	$24.52B	$22.93B
Other Short Term Investments	$393.00M	$417.00M	$1.07B
Cash And Cash Equivalents	$19.71B	$24.11B	$21.86B
Cash Equivalents	$16.41B	$21.19B	$18.52B
Cash Financial	$3.30B	$2.92B	$3.34B
Current Assets	$55.62B	$55.89B	$53.49B
Other Current Assets	-	-	-
2. Long Term Assets
Tangible Book Value	$-17.63B	$-10.33B	$-1.96B
Net Tangible Assets	$-17.63B	$-10.33B	$-1.96B
Employee Benefits	$6.96B	$7.25B	$7.15B
Other Non Current Assets	$14.37B	$11.41B	$14.15B
Non Current Deferred Assets	$6.87B	$10.46B	$9.28B
Non Current Deferred Taxes Assets	$6.87B	$10.46B	$9.28B
Goodwill And Other Intangible Assets	$99.17B	$81.82B	$70.73B
Other Intangible Assets	$50.40B	$37.62B	$34.17B
Goodwill	$48.77B	$44.20B	$36.56B
Net PPE	$23.17B	$20.52B	$19.90B
Accumulated Depreciation	$-31.20B	$-28.25B	$-27.88B
Gross PPE	$54.36B	$48.77B	$47.78B
Construction In Progress	$7.36B	$6.29B	$5.63B
Machinery Furniture Equipment	$32.87B	$29.44B	$28.98B
Buildings And Improvements	$13.43B	$12.32B	$12.38B
Land And Improvements	$701.00M	$718.00M	$795.00M
Properties	$0.00	$0.00	$0.00
Finished Goods	$7.83B	$7.29B	$6.87B
Work In Process	$3.83B	$2.81B	$1.95B
Raw Materials	$2.53B	$2.34B	$2.35B
Total Non Current Assets	$143.59B	$124.21B	$114.06B
Total Assets	$199.21B	$180.10B	$167.56B
2. LIABILITIES
1. Current Liabilities
Current Debt And Capital Lease Obligation	$8.49B	$5.98B	$3.45B
Current Debt	$8.49B	$5.98B	$3.45B
Other Current Borrowings	$8.49B	$5.98B	-
Payables And Accrued Expenses	$41.10B	$40.21B	$38.84B
Current Accrued Expenses	$27.72B	$26.13B	$26.21B
Payables	$13.38B	$14.08B	$12.62B
Total Tax Payable	$1.39B	$3.77B	$2.99B
Income Tax Payable	$1.39B	$3.77B	$2.99B
Accounts Payable	$11.99B	$10.31B	$9.63B
Current Liabilities	$54.13B	$50.32B	$46.28B
Other Current Liabilities	-	-	-
2. Long Term Liabilities
Net Debt	$28.22B	$12.53B	$7.47B
Total Debt	$47.93B	$36.63B	$29.33B
Other Non Current Liabilities	$9.87B	$17.55B	$13.40B
Liabilities Heldfor Sale Non Current	-	-	$0.00
Tradeand Other Payables Non Current	$486.00M	$390.00M	$2.88B
Non Current Deferred Liabilities	$6.79B	$2.45B	$3.19B
Non Current Deferred Taxes Liabilities	$6.79B	$2.45B	$3.19B
Long Term Debt And Capital Lease Obligation	$39.44B	$30.65B	$25.88B
Long Term Debt	$39.44B	$30.65B	$25.88B
Total Non Current Liabilities Net Minority Interest	$63.54B	$58.29B	$52.50B
Total Liabilities Net Minority Interest	$117.67B	$108.61B	$98.78B
3. STOCKHOLDERS' EQUITY
1. Retained Earnings
Retained Earnings	-	-	$153.84B
2. Other Stockholders' Equity
Treasury Shares Number	711.90M	712.92M	712.76M
Ordinary Shares Number	2.41B	2.41B	2.41B
Share Issued	$3.12B	$3.12B	$3.12B
Invested Capital	$129.48B	$108.12B	$98.11B
Common Stock Equity	$81.54B	$71.49B	$68.77B
Total Capitalization	$120.98B	$102.14B	$94.66B
Gains Losses Not Affecting Retained Earnings	$-14.93B	$-11.74B	$-12.53B
Other Equity Adjustments	$-14.93B	$-11.74B	$-12.53B
Treasury Stock	$75.62B	$75.68B	$75.66B
Additional Paid In Capital	$168.98B	$155.79B	$153.84B
Capital Stock	$3.12B	$3.12B	$3.12B
Common Stock	$3.12B	$3.12B	$3.12B
Preferred Stock	$0.00	$0.00	$0.00
Stockholders Equity	$81.54B	$71.49B	$68.77B

Financial Line Item	2025-12-31	2024-12-31	2023-12-31
1. CASH FLOW FROM OPERATING ACTIVITIES
Free Cash Flow	$19.31B	$18.06B	$17.78B
Interest Paid Supplemental Data	$1.98B	$1.99B	$1.84B
Income Tax Paid Supplemental Data	$6.54B	$6.71B	$8.57B
Effect Of Exchange Rate Changes	$201.00M	$-289.00M	$-112.00M
Common Stock Payments	$-5.95B	$-2.43B	$-5.05B
Short Term Debt Payments	$-12.33B	$-9.46B	$-22.97B
Long Term Debt Payments	$-1.76B	$-2.42B	$-1.55B
Net Business Purchase And Sale	$-17.54B	$-15.15B	$0.00
Net Intangibles Purchase And Sale	$-385.00M	$-1.78B	$-470.00M
Net PPE Purchase And Sale	$-4.83B	$-4.42B	$-4.54B
Change In Working Capital	$-12.72B	$1.84B	$2.51B
Change In Other Current Liabilities	$-5.70B	$33.00M	$5.59B
Change In Other Current Assets	$-6.17B	$1.72B	$-3.48B
Change In Payables And Accrued Expense	$2.38B	$1.62B	$2.35B
Change In Inventory	$-1.45B	$-1.13B	$-1.32B
Change In Receivables	$-1.78B	$-406.00M	$-624.00M
Changes In Account Receivables	$-1.78B	$-406.00M	$-624.00M
Other Non Cash Items	$109.00M	$1.84B	$483.00M
Stock Based Compensation	$1.35B	$1.18B	$1.16B
Provisionand Write Offof Assets	$-1.00M	$11.00M	$0.00
Asset Impairment Charge	$204.00M	$405.00M	$1.29B
Deferred Tax	$1.54B	$-2.18B	$-4.19B
Deferred Income Tax	$1.54B	$-2.18B	$-4.19B
Depreciation Amortization Depletion	$7.50B	$7.34B	$7.49B
Depreciation And Amortization	$7.50B	$7.34B	$7.49B
Operating Gains Losses	$-263.00M	$-226.00M	$-21.10B
Net Income From Continuing Operations	$26.80B	$14.07B	$35.15B
Operating Cash Flow	$24.53B	$24.27B	$22.79B
Cash Flow From Continuing Operating Activities	$24.53B	$24.27B	$22.79B
2. CASH FLOW FROM INVESTING ACTIVITIES
Repurchase Of Capital Stock	$-5.95B	$-2.43B	$-5.05B
Capital Expenditure	$-5.22B	$-6.21B	$-5.01B
Net Other Investing Changes	$-1.57B	$2.02B	$-2.59B
Net Investment Purchase And Sale	$741.00M	$736.00M	$8.48B
Sale Of Investment	$1.66B	$2.46B	$19.39B
Purchase Of Investment	$-920.00M	$-1.73B	$-10.91B
Purchase Of Business	$-17.54B	$-15.15B	$0.00
Purchase Of Intangibles	$-385.00M	$-1.78B	$-470.00M
Purchase Of PPE	$-4.83B	$-4.42B	$-4.54B
Gain Loss On Sale Of Business	$-263.00M	$-226.00M	$-21.10B
Investing Cash Flow	$-23.59B	$-18.60B	$878.00M
Cash Flow From Continuing Investing Activities	$-23.59B	$-18.60B	$878.00M
3. CASH FLOW FROM FINANCING ACTIVITIES
Repayment Of Debt	$-14.09B	$-11.89B	$-24.52B
Issuance Of Debt	$23.72B	$21.94B	$21.79B
Issuance Of Capital Stock	$0.00	$0.00	$4.24B
Net Other Financing Charges	$-260.00M	$234.00M	$-1.60B
Proceeds From Stock Option Exercised	$3.42B	$838.00M	$1.09B
Cash Dividends Paid	$-12.38B	$-11.82B	$-11.77B
Common Stock Dividend Paid	$-12.38B	$-11.82B	$-11.77B
Net Common Stock Issuance	$-5.95B	$-2.43B	$-813.00M
Common Stock Issuance	$0.00	$0.00	$4.24B
Net Issuance Payments Of Debt	$9.64B	$10.05B	$-2.73B
Net Short Term Debt Issuance	$2.26B	$5.81B	$-1.18B
Short Term Debt Issuance	$14.59B	$15.28B	$21.79B
Net Long Term Debt Issuance	$7.38B	$4.24B	$-1.55B
Long Term Debt Issuance	$9.14B	$6.66B	$0.00
Financing Cash Flow	$-5.54B	$-3.13B	$-15.82B
Cash Flow From Continuing Financing Activities	$-5.54B	$-3.13B	$-15.82B
4. CASH RECONCILIATION
Beginning Cash Position	$24.11B	$21.86B	$14.13B
Changes In Cash	$-4.60B	$2.54B	$7.84B
End Cash Position	$19.71B	$24.11B	$21.86B

FINANCIAL RATIOS & STATS

Financial Metric	Value
Trailing P/E	39.36x
Forward P/E	22.32x
Price-to-Book (P/B)	7.35x
Price-to-Sales (P/S)	6.29x
Net Profit Margin (Net Income / Revenue)	16.20%
Operating Profit Margin (EBIT / Revenue)	25.06%
Return on Equity (ROE)	N/A
Return on Assets (ROA)	N/A
Dividend Rate	$5.36
Dividend Yield	2.07%
Ex-Dividend Date	2026-11-24
Next Earnings Date	2026-10-13